Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
INO: INO-3107 BLA under FDA review; cash runway extended into Q4 2026 amid focused pipeline progress
Inovio Pharmaceuticals (INO) has its BLA for INO-3107 under FDA review with a PDUFA date set for October 30, 2026, and is actively preparing for its commercial launch. The company has extended its cash runway into Q4 2026 by reducing operating expenses and headcount, while continuing to advance its pipeline through strategic partnerships. This information is based on their Q4 2025 audio transcript.